Literature DB >> 17239402

Activities of enzymes that hydrolyze adenine nucleotides in platelets from rats experimentally demyelinated with ethidium bromide and treated with interferon-beta.

Roselia M Spanevello1, Cinthia M Mazzanti, Paula A Maldonado, Rafael Zanin, André Morsch, Laura Hannel, Alexandre Mazzanti, Rafael Festugatto, Dominguita Graça, Roberta Schmatz, Vânia Lúcia Loro, Maria Rosa C Schetinger, Vera M Morsch.   

Abstract

The activities of the enzymes NTPDase (EC 3.6.1.5, apyrase, CD39) and 5'-nucleotidase (EC 3.1.3.5, CD73) were analyzed in platelets from rats submitted to demyelination by ethidium bromide (EB) and treated with interferon beta (IFN-beta). The following groups were studied: I - control (saline), II - (saline and IFN-beta), III - (EB) and IV - (EB and IFN-beta). After 7, 15 and 30 days, the animals (n=7) were sacrificed and the platelets were separated by the method of Lunkes et al. [Lunkes, G., Lunkes D., Morsch, V., Mazzanti, C., Morsch, A., Miron, V., Schetinger, M.R.C., 2004. NTPDase and 5'-nucleotidase in rats alloxan- induced diabetes. Diabetes Research and Clinical Practice 65, 1-6]. NTPDase activity for ATP and ADP substrates was significantly lower in groups II and III after seven days, when compared to control (p<0.001). At fifteen days, ATP hydrolysis was significantly lower in group III and IV and higher in group II (p<0.001), while there was an activation of ADP hydrolysis in group II (p<0.001), when compared with the control. 5'-nucleotidase activity was significantly higher in group IV (p<0.001) after seven days, and lower in the groups III and IV (p<0.001) after fifteen days in relation to the control. No significant differences were observed in NTPDase and 5'-nucleotidase activities after thirty days. In conclusion, our study demonstrated that the hydrolysis of adenine nucleotides is modified in platelets of rats demyelinated and treated with IFN-beta.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17239402     DOI: 10.1016/j.lfs.2006.11.049

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Activities of the enzymes that hydrolyze adenine nucleotides in platelets from multiple sclerosis patients.

Authors:  Roselia Maria Spanevello; Cinthia Melazzo Mazzanti; Margarete Bagatini; Maisa Correa; Roberta Schmatz; Naiara Stefanello; Gustavo Thomé; Vera Maria Morsch; Lara Becker; Luziane Bellé; Liliane de Oliveira; Maria Rosa Chitolina Schetinger
Journal:  J Neurol       Date:  2009-07-24       Impact factor: 4.849

2.  Effects in vitro of guanidinoacetate on adenine nucleotide hydrolysis and acetylcholinesterase activity in tissues from adult rats.

Authors:  Roselia Maria Spanevello; Angela Terezinha de Souza Wyse; Cinthia Melazzo Mazzanti; Roberta Schmatz; Naiara Stefanello; Jamile Fabbrin Gonçalves; Margarete Bagatini; Vanessa Battisti; Vera Maria Morsch; Maria Rosa Chitolina Schetinger
Journal:  Neurochem Res       Date:  2008-02-07       Impact factor: 3.996

3.  Brain Injury Alters Ectonucleotidase Activities and Adenine Nucleotide Levels in Rat Serum.

Authors:  Danijela Laketa; Jasmina Savić; Ivana Bjelobaba; Irena Lavrnja; Vesna Vasić; Mirjana Stojiljković; Nadežda Nedeljković
Journal:  J Med Biochem       Date:  2015-03-03       Impact factor: 3.402

Review 4.  The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases.

Authors:  Margarete Dulce Bagatini; Alessandra Antunes Dos Santos; Andréia Machado Cardoso; Aline Mânica; Cristina Ruedell Reschke; Fabiano Barbosa Carvalho
Journal:  J Immunol Res       Date:  2018-08-12       Impact factor: 4.818

5.  The Molecular Aspects of Disturbed Platelet Activation through ADP/P2Y12 Pathway in Multiple Sclerosis.

Authors:  Angela Dziedzic; Elzbieta Miller; Joanna Saluk-Bijak; Marta Niwald; Michal Bijak
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

Review 6.  Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.

Authors:  Júlia Leão Batista Simões; Julia Beatrice de Araújo; Margarete Dulce Bagatini
Journal:  Mol Neurobiol       Date:  2021-07-11       Impact factor: 5.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.